Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.
Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
[Association between depression and cognitive decline in sclerosis multiplex patients].
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
Hope for a rare disease: eculizumab in neuromyelitis optica.
A case with neuromyelitis optica mimicking Susac's syndrome.
Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Impact of multiple sclerosis relapses on progression diminishes with time.
[The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis.]
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Rising incidence of multiple sclerosis in females associated with urbanization.
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Pages
« first
‹ previous
…
204
205
206
207
208
209
210
211
212
…
next ›
last »